Mitsubishi Corporation (LON:0Q0J)

CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	57,256	53,986	75,080	41,399	42,554	30,320
Market Cap Growth	-28.09%	-28.09%	81.36%	-2.71%	40.35%	18.88%
Enterprise Value	80,085	79,917	107,063	77,944	84,536	73,885
Last Close Price	15.23	13.96	-	-	-	-
PE Ratio	11.65	10.99	14.88	5.77	7.25	26.77
PS Ratio	0.60	0.56	0.73	0.32	0.39	0.36
PB Ratio	1.09	1.03	1.42	0.75	0.87	0.71
P/TBV Ratio	1.29	1.21	1.73	0.99	1.20	1.06
P/FCF Ratio	8.69	8.20	17.35	4.62	10.26	7.35
P/OCF Ratio	6.68	6.30	10.65	3.53	6.43	4.54
EV/Sales Ratio	0.84	0.83	1.05	0.59	0.78	0.87
EV/EBITDA Ratio	13.81	22.03	22.15	10.52	13.58	24.69
EV/EBIT Ratio	22.62	43.29	31.96	14.08	18.23	50.81
EV/FCF Ratio	12.16	12.14	24.74	8.69	20.38	17.91
Debt / Equity Ratio	0.53	0.53	0.56	0.72	0.92	1.10
Debt / EBITDA Ratio	6.67	6.67	4.73	4.39	5.78	10.10
Debt / FCF Ratio	4.19	4.19	6.88	4.45	10.93	11.43
Asset Turnover	0.83	0.83	0.86	0.98	0.85	0.70
Inventory Turnover	9.63	9.63	9.85	10.72	9.67	8.53
Quick Ratio	0.99	0.99	0.69	0.87	0.82	0.89
Current Ratio	1.49	1.49	1.44	1.36	1.30	1.32
Return on Equity (ROE)	10.63%	10.63%	10.67%	14.98%	13.96%	2.07%
Return on Assets (ROA)	0.99%	0.99%	1.75%	2.58%	2.28%	0.76%
Return on Capital (ROIC)	1.43%	1.43%	2.54%	3.70%	3.21%	1.02%
Return on Capital Employed (ROCE)	2.30%	2.30%	4.20%	5.90%	5.10%	1.70%
Earnings Yield	8.58%	9.10%	6.72%	17.34%	13.80%	3.74%
FCF Yield	11.50%	12.20%	5.76%	21.67%	9.75%	13.61%
Dividend Yield	243.15%	3.70%	-	-	-	-
Payout Ratio	36.00%	36.00%	30.44%	19.38%	21.73%	115.82%
Buyback Yield / Dilution	4.21%	4.21%	4.26%	1.11%	-0.11%	3.86%
Total Shareholder Return	247.36%	7.92%	4.26%	1.11%	-0.11%	3.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.